Target To Treatment Consulting


Pauline Lukey (Director and Founder) has extensive experience as an early development leader within the pharmaceutical industry (20 years); leading all aspects of projects from target identification, through candidate selection and first dose in humans up to clinical proof of concept. Her therapeutic expertise is in tuberculosis (8 years), rheumatoid arthritis (6 years) and fibrosis (6 years). She has led both small molecule and biopharm projects through discovery and early clinical development. She has an MSc in microbiology and genetics and a PhD in immunology. She is also a honorary senior lecturer in immunology at the London School of Hygiene and Tropical Medicine.

She recently, retired from GSK and is working as a consultant to the pharmaceutical industry, biotech and academia. 

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.